Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometriosis | 13 | 2024 | 874 | 4.080 |
Why?
|
| Ovarian Neoplasms | 19 | 2024 | 4876 | 2.620 |
Why?
|
| CA-125 Antigen | 5 | 2021 | 279 | 2.500 |
Why?
|
| Pelvic Pain | 6 | 2024 | 298 | 1.590 |
Why?
|
| Dysmenorrhea | 4 | 2024 | 98 | 1.310 |
Why?
|
| Dyspareunia | 1 | 2022 | 48 | 0.810 |
Why?
|
| Biological Specimen Banks | 2 | 2024 | 782 | 0.770 |
Why?
|
| Postmenopause | 2 | 2021 | 2509 | 0.750 |
Why?
|
| Mexican Americans | 1 | 2021 | 165 | 0.690 |
Why?
|
| Early Detection of Cancer | 3 | 2023 | 3211 | 0.630 |
Why?
|
| Blood Proteins | 1 | 2024 | 1173 | 0.630 |
Why?
|
| Nutrition Assessment | 1 | 2021 | 726 | 0.590 |
Why?
|
| Mucin-1 | 1 | 2021 | 539 | 0.530 |
Why?
|
| Laparoscopy | 4 | 2024 | 2147 | 0.510 |
Why?
|
| Premenopause | 1 | 2019 | 1038 | 0.480 |
Why?
|
| Membrane Proteins | 3 | 2021 | 7843 | 0.480 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2020 | 812 | 0.470 |
Why?
|
| Analgesics | 1 | 2021 | 1064 | 0.460 |
Why?
|
| Telomere | 1 | 2020 | 931 | 0.460 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1826 | 0.430 |
Why?
|
| Turner Syndrome | 1 | 2014 | 130 | 0.420 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2022 | 479 | 0.400 |
Why?
|
| Menstruation | 1 | 2014 | 307 | 0.400 |
Why?
|
| Aspirin | 1 | 2023 | 3132 | 0.380 |
Why?
|
| Case-Control Studies | 10 | 2024 | 22031 | 0.380 |
Why?
|
| Anemia, Neonatal | 1 | 2011 | 19 | 0.380 |
Why?
|
| Blood Group Antigens | 1 | 2011 | 187 | 0.330 |
Why?
|
| Proteomics | 4 | 2024 | 3816 | 0.330 |
Why?
|
| Female | 39 | 2024 | 390316 | 0.310 |
Why?
|
| Parity | 2 | 2021 | 925 | 0.300 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3561 | 0.290 |
Why?
|
| Isoantibodies | 1 | 2011 | 661 | 0.290 |
Why?
|
| Pain | 2 | 2022 | 5065 | 0.270 |
Why?
|
| Adult | 23 | 2024 | 219916 | 0.260 |
Why?
|
| Young Adult | 12 | 2024 | 58808 | 0.240 |
Why?
|
| Endometrial Neoplasms | 1 | 2014 | 1357 | 0.240 |
Why?
|
| Exercise | 1 | 2021 | 5788 | 0.230 |
Why?
|
| Diet | 1 | 2022 | 8003 | 0.230 |
Why?
|
| Prospective Studies | 9 | 2024 | 54136 | 0.220 |
Why?
|
| Humans | 41 | 2024 | 758381 | 0.220 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 1718 | 0.220 |
Why?
|
| Tea | 1 | 2024 | 284 | 0.210 |
Why?
|
| Pain, Postoperative | 2 | 2024 | 1721 | 0.210 |
Why?
|
| Sjogren's Syndrome | 1 | 2024 | 235 | 0.210 |
Why?
|
| Carcinoma | 2 | 2023 | 2330 | 0.190 |
Why?
|
| New England | 2 | 2021 | 1053 | 0.190 |
Why?
|
| Adolescent | 9 | 2024 | 87888 | 0.190 |
Why?
|
| Transcytosis | 1 | 2021 | 45 | 0.180 |
Why?
|
| Risk Factors | 9 | 2024 | 73806 | 0.180 |
Why?
|
| Coffee | 1 | 2024 | 582 | 0.170 |
Why?
|
| Intrauterine Devices | 1 | 2021 | 114 | 0.170 |
Why?
|
| Contraceptives, Oral | 1 | 2021 | 554 | 0.160 |
Why?
|
| Neoplasms | 3 | 2024 | 22030 | 0.150 |
Why?
|
| Middle Aged | 13 | 2024 | 219560 | 0.150 |
Why?
|
| Pelvis | 1 | 2022 | 743 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2022 | 707 | 0.140 |
Why?
|
| 5-Methylcytosine | 1 | 2017 | 146 | 0.140 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 979 | 0.140 |
Why?
|
| Abdominal Pain | 1 | 2023 | 1063 | 0.140 |
Why?
|
| Epithelium, Corneal | 1 | 2019 | 249 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2024 | 1927 | 0.140 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 3840 | 0.140 |
Why?
|
| Estrogens | 1 | 2023 | 1520 | 0.140 |
Why?
|
| Nandrolone | 1 | 2016 | 17 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 6313 | 0.130 |
Why?
|
| Aged | 12 | 2024 | 168217 | 0.130 |
Why?
|
| Pregnancy | 6 | 2021 | 29742 | 0.130 |
Why?
|
| Hormone Antagonists | 1 | 2016 | 108 | 0.130 |
Why?
|
| Japan | 3 | 2021 | 1366 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2021 | 1573 | 0.120 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 694 | 0.120 |
Why?
|
| Ovarian Diseases | 1 | 2016 | 137 | 0.120 |
Why?
|
| Causality | 1 | 2021 | 1241 | 0.120 |
Why?
|
| Abortion, Spontaneous | 1 | 2019 | 530 | 0.120 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 1348 | 0.120 |
Why?
|
| Salpingectomy | 1 | 2014 | 48 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 1765 | 0.110 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 39060 | 0.110 |
Why?
|
| Proportional Hazards Models | 3 | 2024 | 12440 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2021 | 2772 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1997 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2021 | 1406 | 0.100 |
Why?
|
| Prevalence | 3 | 2024 | 15646 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2020 | 1355 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 25953 | 0.100 |
Why?
|
| Ovariectomy | 1 | 2014 | 610 | 0.100 |
Why?
|
| Nurses | 1 | 2021 | 2467 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2270 | 0.090 |
Why?
|
| Fetal Monitoring | 1 | 2011 | 69 | 0.090 |
Why?
|
| Lipids | 1 | 2022 | 3326 | 0.090 |
Why?
|
| Health Surveys | 1 | 2021 | 4060 | 0.090 |
Why?
|
| Mosaicism | 1 | 2014 | 465 | 0.090 |
Why?
|
| Gene Expression | 1 | 2023 | 7583 | 0.090 |
Why?
|
| United States | 4 | 2022 | 72140 | 0.090 |
Why?
|
| Labor, Induced | 1 | 2011 | 151 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2024 | 41252 | 0.080 |
Why?
|
| Middle Cerebral Artery | 1 | 2011 | 275 | 0.080 |
Why?
|
| Boston | 1 | 2022 | 9304 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 2125 | 0.080 |
Why?
|
| Women's Health | 1 | 2019 | 2057 | 0.080 |
Why?
|
| Comorbidity | 1 | 2024 | 10495 | 0.080 |
Why?
|
| Epidemiologic Studies | 2 | 2023 | 670 | 0.080 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2011 | 582 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 14641 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 732 | 0.080 |
Why?
|
| Hysterectomy | 1 | 2014 | 904 | 0.080 |
Why?
|
| Mass Screening | 1 | 2023 | 5425 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 14481 | 0.070 |
Why?
|
| Lymph Node Excision | 1 | 2014 | 1303 | 0.070 |
Why?
|
| Age Factors | 2 | 2021 | 18357 | 0.070 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 1370 | 0.070 |
Why?
|
| Stem Cells | 1 | 2019 | 3521 | 0.070 |
Why?
|
| Inflammation | 2 | 2024 | 10719 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2942 | 0.060 |
Why?
|
| Registries | 1 | 2021 | 8176 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3754 | 0.060 |
Why?
|
| Prognosis | 3 | 2021 | 29558 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2011 | 1745 | 0.050 |
Why?
|
| Cyclin E | 1 | 2022 | 156 | 0.050 |
Why?
|
| Caffeine | 1 | 2024 | 701 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 13959 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2021 | 631 | 0.040 |
Why?
|
| Premature Birth | 1 | 2011 | 1771 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2021 | 1060 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 2022 | 719 | 0.040 |
Why?
|
| Limbus Corneae | 1 | 2019 | 144 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2021 | 535 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2022 | 12760 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2021 | 26182 | 0.030 |
Why?
|
| Propensity Score | 1 | 2024 | 1907 | 0.030 |
Why?
|
| Child | 2 | 2023 | 79813 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2017 | 332 | 0.030 |
Why?
|
| Recurrence | 2 | 2017 | 8426 | 0.030 |
Why?
|
| Cell Separation | 1 | 2019 | 1720 | 0.030 |
Why?
|
| Disease Progression | 2 | 2021 | 13468 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2024 | 2312 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2021 | 3997 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2019 | 2311 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 58681 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2023 | 11070 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3574 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3812 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 2907 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5781 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2019 | 3665 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12721 | 0.020 |
Why?
|
| Risk | 1 | 2019 | 9599 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15594 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2024 | 80170 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10417 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8530 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2016 | 3527 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6821 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 4485 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 10112 | 0.020 |
Why?
|
| Incidence | 1 | 2022 | 21273 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20052 | 0.010 |
Why?
|
| Depression | 1 | 2023 | 8057 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2017 | 4373 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12096 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8506 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 13286 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9575 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18125 | 0.010 |
Why?
|
| Male | 2 | 2022 | 358742 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 81107 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 167777 | 0.000 |
Why?
|
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_